Delivery Order SPE2DB24D1021-SPE2DB25FEXDT

Award Date 5/29/25
Potential Completion Date 5/30/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has a ceiling value of $1,485.16 and an ultimate completion date of August 14, 2024. The contract is a Firm Fixed Price type with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, with a ceiling value of $2,147.48 and a completion date of May 27, 2025. The contract is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a ceiling value of $1,821.49 and a performance period ending on May 16, 2025. The contract is a firm fixed-price delivery order, which is not set-aside for any particular business category. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NAYZILAM 5 mg nasal sprays, with a ceiling value of $2,388.74 and a period of performance ending on April 1, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has a ceiling value of $1,344.52 and a completion date of August 12, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, the prime contractor, will be responsible for delivering the medical supplies to the specified location in Conshohocken, Pennsylvania....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product, with a ceiling value of $3,477.50 and a final completion date of January 16, 2025. The contract is a firm fixed-price delivery order, and there was no set-aside designation used. AmerisourceBergen holds a significant...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The delivery order has a ceiling value of $1,344.52 and a completion date of September 6, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a ceiling value of $1,481.32 and a period of performance through August 13, 2024. The contract is a firm fixed-price type and does not have any set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite...
This is a $1,061.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of August 1, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,516,455 units of NAYZILAM 5 MG NASAL SPRAYS. The contract has a completion date of February 2, 2024 and a potential value of $1,344.52. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEXDT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, with a ceiling value of $1,043.25 and a completion date of May 30, 2025. The contract type is Firm Fixed Price.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is a part of that larger IDC contract vehicle.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors.

Generated 8/28/25, 10:01 AM